Tissue-based Genomic Profiling Market are Upgrading Oncological Diagnostic Solutions: FMI Predicts t
In 2023, the Tissue-Based Genomic Profiling Market is expected to be worth US$ 1.2 billion. The market is expected to reach US$ 2.2 billion by 2033, expanding at a 6.6% CAGR throughout the forecast period. In recent years, the market for tissue-based genetic profiling has grown significantly. The market is likely to...
Source: pharmiweb.com